The world's largest vaccine manufacturer by volume said Saturday it would apply for an emergency license for a coronavirus vaccine within two weeks, and that confusion over the efficacy would not delay its distribution.
Dr. Anthony Fauci, the nation’s leading infectious disease expert, is advising Americans who have already had the coronavirus — or suspect that they’ve had it — to take the coming vaccines for it anyway.
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus, Reuters reported.
Asian markets mostly rose on Wednesday but investors were shifting cautiously as they weighed hopes for a virus vaccine against surging infections around the world that threaten an already stuttering economic recovery.
The spokesman of Iran Food and Drug Administration (IFDA) said that five Iranian vaccines were included in the list of candidates of coronavirus, COVID-19, vaccine of the World Health Organization (WHO).
Russia’s Sputnik V vaccine is 92 percent effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.
Scientists said initial trial results for Pfizer Inc. and BioNTech’s coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered.